Health

Results: 6625-6636 of 8695

PR Newswire associated0

Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD)

The Balance HealthCare Group expands luxury mental health and addiction services for UHNW individuals

4 university colleges in Denmark join forces to enhance on-site and remote education for radiographers with Sectra Education Portal

PR Newswire associated0

Indivior Announces Q1 2024 Financial Results

Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US

ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date

Essity's Interim Report, Quarter 1, 2024

Business Wire logo

ICON Reports First Quarter 2024 Results

Business Wire logo

Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area

Business Wire logo

Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting

Calliditas Therapeutics' 2023 Annual Report Published

Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting